Vitamin D, protein, and exercise for muscle loss
Part of Brain & nervous system clinical trials.
This trial tests whether a combination of a vitamin D-like drug (idecalcitol), whey protein powder, and a structured exercise program can help rebuild muscle strength and mass in people with sarcopenia. It lasts about 6 months.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 30 years old or older.
- You have been diagnosed with sarcopenia (age-related muscle loss).
- You can walk on your own.
- You are willing to follow a program that includes a vitamin D supplement, whey protein powder, and exercise.
- You do not have uncontrolled high blood pressure, serious heart disease, or a recent fracture.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a protein powder combined with resistance exercise can improve muscle and bone health in people with sarcopenia (age-related loss of muscle). It may help you become stronger and more mobile.
This trial tests a combined exercise and nutrition program to help older adults with sarcopenia (muscle loss). It aims to improve muscle strength and function, especially for those with metabolic syndrome.
This study tests if a combination of a medicine (nandrolone), physical therapy, and a special diet can help older adults with muscle loss (sarcopenia) improve their strength and muscle mass. It is for people age 60 to 99 who have been diagnosed with sarcopenia based on specific muscle strength and mass measurements.
This trial tests an investigational drug called AMC6156 to see if it can help improve muscle mass and strength in older adults with sarcopenia (age-related muscle loss). Participants will also follow exercise and nutrition guidance.
This study looks at muscle changes in people with or at risk for sarcopenia (age-related muscle loss). It aims to find better ways to detect and manage sarcopenia using simple tests like muscle strength and body composition measurements.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.